Explore by health topic
View allGLP-1
Semaglutide, tirzepatide, retatrutide, side effects, dosing, and access.
Peptides
Recovery, metabolism, skin health, and evidence-based peptide guides.
Drug Guides
Plain-language coverage of major GLP-1 medications and comparisons.
Diet & Side Effects
Food, protein, fiber, nausea, fatigue, reflux, and long-term routines.
Latest
New guides from Middleway
Peptides
5-Amino-1MQ Side Effects: What Users Report and the Data That Is Missing
Reported side effects are mild and few. The more serious issue is that no human trial has ever looked, which is a different situation from a clean safety record.
Peptides
5-Amino-1MQ for Beginners: Dosage Ranges, Mechanism and Realistic Expectations
An NNMT inhibitor with an interesting mechanism, promising mouse data and no human trials. What beginners should understand before deciding anything.
Peptides
10 Evidence-Backed Glutathione Benefits (With Dosage and Food Sources): What to Take and Where to Buy
Ten glutathione benefits with human evidence behind them, the doses used in trials, which foods raise levels, and how to choose a form worth buying.
Peptides
Best Peptide Information Sources in 2026: Where to Research Before You Buy
Six peptide and GLP-1 information sources worth your time in 2026, ranked by how far each one gets you on a compound that carries no FDA label.
GLP-1
Cheapest Semaglutide in 2026: Every Route Ranked by What You Actually Pay
Cheapest semaglutide in 2026, ranked by verified price: $25 savings cards, $125/mo compounded, $149 Wegovy pill, $199 NovoCare intro, $349 ongoing.
GLP-1
Tirzepatide Provider Cost: What Each Route Actually Charges
Tirzepatide provider cost compared across telehealth, LillyDirect, insurance, retail cash and clinics: what each charges, what is bundled, where fees hide.
Peptides
Best Peptide Vendors in 2026
A vendor-trust guide to the best peptide vendors: verified batch COAs, a five-step test you can run in five minutes, and a 130-brand vendor directory.
GLP-1
GLP-1 Medications in 2026: What Each One Does and Who It Suits
Every GLP-1 medication available in 2026, matched to the goal it fits: type 2 diabetes, maximum weight loss, heart and kidney protection, or oral dosing.
Peptides
SLU-PP-332: What the Evidence Actually Shows
SLU-PP-332 is a small-molecule ERR agonist and exercise mimetic. What the rodent research really shows, why no human data exists, and the risks left open.